Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Media for editorial use

chevron_right

Press contact

chevron_right

Our News

View:
format_list_bulleted grid_view

09/21/2023

CHEPLAPHARM succesfully places additional notes in a volume of €300m
Press releases
Read more chevron_right

09/19/2023

Announcement on Pricing
Investors Domain Press releases
Read more chevron_right

09/18/2023

Announcement on Offering
Investors Domain Press releases
Read more chevron_right

09/12/2023

CHEPLAPHARM opens swiss subsidiary and wins Agnes Wasem as Managing Director
Press releases
Read more chevron_right

07/27/2023

CHEPLAPHARM successfully closes acquisition of Zyprexa® portfolio
Press releases
Read more chevron_right

04/28/2023

Cheplapharm places notes in a volume of €750m in challenging market environment
Press releases
Read more chevron_right

04/26/2023

Announcement on Pricing
Press releases
Read more chevron_right

04/24/2023

Announcement on Offering
Press releases
Read more chevron_right

04/22/2023

CHEPLAPHARM announces acquisition of Zyprexa® from Lilly
Press releases
Read more chevron_right

Archive

Back to top expand_less